SCHEMBL19203072

SCHEMBL19203072

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc3c(c2)c2ccccc2n3-c2cc3c4c(cccc4c2)-c2ccccc2-3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
ATM Q13315 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 3/20 0.37
TSHR P16473 3/20 0.37
MAPK1 P28482 3/20 0.37
HSD17B10 Q99714 3/20 0.37
HPGD P15428 2/20 0.37
CASP1 P29466 2/20 0.37
HIF1A Q16665 2/20 0.37
PDE6D O43924 1/20 0.35
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
HDAC4 P56524 1/20 0.33
PDE10A Q9Y233 1/20 0.32
ANPEP P15144 1/20 0.32
CA12 O43570 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19202965 0.96 L3MBTL1 (0.41) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19202698 0.95 L3MBTL1 (0.41) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19202998 0.93 TSPO (0.35) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19203024 0.93 L3MBTL1 (0.39) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19202702 0.92 L3MBTL1 (0.39) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL20466578 0.92 L3MBTL1 (0.42) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19203049 0.92 L3MBTL1 (0.38) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19202964 0.91 ALDH1A1 (0.38) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19202694 0.91 L3MBTL1 (0.47) TSPOL3MBTL1ATMKDM4EALDH1A1
SCHEMBL19203085 0.91 L3MBTL1 (0.44) L3MBTL1ATMKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10790449-B2 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-09-29 US disclosed
US-20170222152-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-03 US disclosed
US-20170222152-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10790449-B2 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device RPL19, LEF1, RPL39 TSPO 1932/4885L3MBTL1 174/4885ATM 2630/4885
US-20170222152-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE RPL19, LEF1, RPL39 TSPO 1932/4885L3MBTL1 174/4885ATM 2630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.